Intravascular ultrasound–guided versus angiography-guided endovascular interventions for peripheral artery disease: a systematic review and meta-analysis

作者
Montserrat Villa Sánchez,Ruth Diaz Revelo,Maya AlQawasmi,Alaa Hamrouni,Nowis Duerto,Lydia del Carmen Hernández Salinas,Valeria Esther Acosta Casana,Muhammad Khalid Hussain,Joseph Than,Stephani Carolina Salvatierra Moreno,Victor Sebastian Arruarana,Ernesto Calderón Martinez
出处
期刊:BMC Cardiovascular Disorders [BioMed Central]
标识
DOI:10.1186/s12872-026-06372-w
摘要

Abstract Background Endovascular revascularization is a cornerstone therapy for peripheral artery disease (PAD), typically guided by angiography, which may underestimate vessel size and lesion complexity. The clinical benefit of intravascular ultrasound (IVUS) guidance remains uncertain. This systemic review and meta-analysis compare clinical outcomes of IVUS-guided versus angiography-guided endovascular interventions in patients with PAD. Methods PubMed/MEDLINE, Cochrane, Scopus, Web of Science, EMBASE, and Google Scholar were searched from inception through January 30, 2026, for randomized and observational studies of adults with PAD undergoing endovascular interventions with IVUS versus angiography. Primary outcomes were primary patency, target lesion revascularization (TLR), and late lumen loss. Secondary outcomes included major adverse limb events, amputation, procedural success, and ankle–brachial index improvement. Random-effects meta-analysis was performed using R version 3.4.3. Results Twenty-three studies encompassing 1,232,018 patients were included. There was no significant difference between IVUS-guided and angiography-guided interventions (RR 1.03; 95% CI 0.81–1.23; p = 0.75; i2 = 60.3%) or freedom from TLR (RR 1.21; 95% CI 0.96–1.54; p = 0.08; I2 = 58.6%). Conclusion IVUS-guided endovascular interventions in PAD were associated with reduced all-cause mortality, but similar limb-related outcomes compared with angiography guidance. However, these findings are based predominantly on observational evidence. Large-scale randomized trials are needed to confirm these findings and identify patient subgroups that would benefit from IVUS-guided strategies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
土豪的新波完成签到,获得积分10
刚刚
刚刚
辛勤的雨灵完成签到,获得积分10
1秒前
彭于晏的应助被娜娜子欧采纳,获得10
1秒前
搜集达人的应助被天行者采纳,获得10
2秒前
bao发布了新的文献求助10
2秒前
慕青的应助被乐乐采纳,获得10
2秒前
2秒前
妍宝贝完成签到 ,获得积分10
2秒前
lu完成签到,获得积分10
2秒前
甘宁完成签到,获得积分10
2秒前
紧张的铅笔完成签到,获得积分10
3秒前
3秒前
seven发布了新的文献求助10
3秒前
3秒前
qiushui发布了新的文献求助10
3秒前
Irene完成签到,获得积分10
3秒前
鹿林洲岸完成签到,获得积分10
3秒前
传奇3的应助被okok采纳,获得10
3秒前
冷酷的向日葵完成签到,获得积分10
4秒前
dasfsdf完成签到,获得积分0
4秒前
4秒前
灵犀完成签到 ,获得积分10
5秒前
英俊的铭的应助被嘎嘣脆采纳,获得10
5秒前
lg完成签到,获得积分10
5秒前
李爱国的应助被科研通管家采纳,获得10
5秒前
Akim的应助被科研通管家采纳,获得10
6秒前
Mm11的应助被科研通管家采纳,获得10
6秒前
文LL发布了新的文献求助10
6秒前
香蕉觅云的应助被科研通管家采纳,获得10
6秒前
依妍发布了新的文献求助10
6秒前
英姑的应助被科研通管家采纳,获得10
6秒前
6秒前
慕青的应助被科研通管家采纳,获得10
6秒前
传奇3的应助被朱朱叹气采纳,获得10
6秒前
密友发布了新的文献求助10
6秒前
小太阳完成签到,获得积分10
7秒前
平常的仙人掌完成签到,获得积分10
7秒前
蛙蛙完成签到,获得积分0
7秒前
303完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Spec 401: Standards for Jet Fuel Facility and Equipment Commissioning and Flushing at Airports, 2026.1 (Original Issue) 1000
Spec 103: Standard for Jet Fuel Quality Control at Airports, Revision 2026.1 1000
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8084892
求助须知:如何正确求助?哪些是违规求助? 9499333
关于积分的说明 21412769
捐赠科研通 7653485
什么是DOI,文献DOI怎么找? 3402691
关于科研通互助平台的介绍 2531849
邀请新用户注册赠送积分活动 2441298